Biotech & Life SciencesDefense & SpaceFood & AgricultureInfrastructure & CloudClimate & EnergyManufacturingCybersecurityInsuranceAIHealthcare
Omnes Capital is a European private equity firm primarily focused on the energy transition and sustainable development. The firm's strategy involves investing in four key areas: renewable energy, sustainable cities, deeptech, and co-investment, aiming to provide capital for growth, scale businesses, and finance essential real assets while integrating ESG principles.
Their most common stage is series-a (42% of deals). Average disclosed round size is $39.6M (across 19 rounds with reported amounts).
Portfolio
19
Fund Size
$7.9B
Top Stage
Series A
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
19 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CCaracol | Series B | $40M | Oct 2025 |
| SSkynopy | Unknown | $15M | Jun 2025 |
 Proxima Fusion | Series A | $130M | Jun 2025 |
 Sekoia.io | Series B | $26M | Apr 2025 |
 Coave Therapeutics | Series A | $33M | Jan 2025 |
 Qantev | Series B | $30M | Oct 2024 |
| CCarbyon | Series A | $15.3M | Sep 2024 |
| UUnseenlabs | Series C | $92M | Feb 2024 |
 Planet A Foods | Series A | $15.4M | Feb 2024 |
| Planet A Foods | Series A | $15.4M | Dec 2023 |
 Quantum Systems | Series B | $63.6M | Oct 2023 |
 Iktos | Series A | $15.5M | Mar 2023 |
 The Exploration Company | Series A | $40M | Feb 2023 |
 Gourmey | Series A | $48M | Oct 2022 |
 WhiteLab Genomics | Seed | $10M | Sep 2022 |
 Therapixel | Series B | $15M | May 2022 |
| AAgomAb Therapeutics | Series B | $74M | Mar 2021 |
 Enterome SA | Series E | $52.6M | Jun 2020 |
| SScality | Series C | $22M | Jul 2013 |
Top Co-Investors
Bpifrance4 shared
Cherry Ventures4 shared
Elaia2 shared
Heartcore Capital2 shared
World Fund2 shared
Nucleus Capital2 shared
Mudcake2 shared
Partech2 shared
Blossom Capital1 shared
Raise Ventures1 shared
Alven1 shared
Supernova Invest1 shared
ISALT1 shared
360 Capital1 shared
S2G Ventures1 shared
M Ventures1 shared
Debiopharm Innovation Fund1 shared
Triple Point Ventures1 shared
Siemens Financial Services1 shared
Invest-NL1 shared
Last updated: 16 April 2026